This study was designed as a pilot single-center, open-label study of 2 months treatment. Following the enrollment & baseline visit participants will be provided with personalized VIZO glasses. Assessment of the immediate effect of VIZO glasses on attentional performance will be assessed by conducting standardized tests of a attention twice. The first assessment will be conducted wearing standard eyeglasses (with no peripheral retinal stimulation), after 10 minutes the assessment will be conducted again, wearing VIZO Glasses. The participants will be then instructed to wear VIZO glasses throughout the day for a period of 2 months. At the end of the treatment period a follow up visit will be conducted assessing the efficacy of VIZO Glasses on managing ADHD symptoms, using the Conners Continuous Performance Test-3, the Adult ADHD Self-Report Scale (ASRS), Behavior Rating Inventory of Executive Function Adults (BRIEF-A), and Clinical Global Impression-Improvement (CGI-I) .
This is a 2-months study, where eligible ADHD adult participants will be provided with personalized VIZO glasses.